Intratumoral Cancer Therapies Market Overview
The Intratumoral Cancer Therapies Market is experiencing rapid expansion as oncology shifts toward localized treatment approaches. Valued at USD 2.7 billion in 2024, the market is projected to reach USD 9.8 billion by 2035, growing at a CAGR of 12.4%. Intratumoral therapies involve direct administration of therapeutic agents into tumor sites, maximizing drug concentration at the target while...
0 Comments 0 Shares 88 Views 0 Reviews